TuHURA Biosciences, Inc. (HURA)

TuHURA Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	3.67	3.67	14.25
Cash & Short-Term Investments	3.67	3.67	14.25
Cash Growth	-	-74.29%	-
Receivables	-	-	0.1
Other Current Assets	0.49	0.49	0.39
Total Current Assets	4.16	4.16	14.74
Property, Plant & Equipment	0.2	0.2	0.42
Other Long-Term Assets	-	-	0.03
Total Assets	4.36	4.36	15.2
Accounts Payable	1.87	1.87	1.92
Accrued Expenses	1.57	1.57	0.84
Current Portion of Leases	0.02	0.02	0.12
Other Current Liabilities	0.14	0.14	-
Total Current Liabilities	3.6	3.6	2.87
Long-Term Debt	2.32	2.32	-
Long-Term Leases	-	-	0.02
Total Liabilities	5.92	5.92	2.89
Common Stock	0.01	0.01	0
Additional Paid-In Capital	86.9	86.9	71.45
Retained Earnings	-88.47	-88.47	-59.16
Total Common Equity	-1.57	-1.57	12.3
Shareholders' Equity	-1.56	-1.56	12.3
Total Liabilities & Equity	4.36	4.36	15.2
Total Debt	2.34	2.34	0.14
Net Cash (Debt)	1.32	1.32	14.11
Net Cash Growth	-	-90.65%	-
Net Cash Per Share	0.02	0.02	-
Filing Date Shares Outstanding	68.01	68.01	-
Total Common Shares Outstanding	68.01	68.01	-
Working Capital	0.56	0.56	11.87
Book Value Per Share	-0.02	-0.02	-
Tangible Book Value	-1.57	-1.57	12.3
Tangible Book Value Per Share	-0.02	-0.02	-
Machinery	1.54	1.54	1.5
Leasehold Improvements	0.54	0.54	0.54

Source: S&P Capital IQ. Standard template. Financial Sources.